William H. Chambers

4.4k total citations · 1 hit paper
88 papers, 3.3k citations indexed

About

William H. Chambers is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, William H. Chambers has authored 88 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 23 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in William H. Chambers's work include Immune Cell Function and Interaction (44 papers), Immunotherapy and Immune Responses (25 papers) and T-cell and B-cell Immunology (19 papers). William H. Chambers is often cited by papers focused on Immune Cell Function and Interaction (44 papers), Immunotherapy and Immune Responses (25 papers) and T-cell and B-cell Immunology (19 papers). William H. Chambers collaborates with scholars based in United States, Germany and Netherlands. William H. Chambers's co-authors include Ronald B. Herberman, John C. Hiserodt, Hideho Okada, Richard P. Kitson, Jay M. Weiss, Nikola L. Vujanović, Ian F. Pollack, Michael W. Olszowy, Karen Bulloch and Kenneth W. Brunson and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

William H. Chambers

85 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions

1997 654 citations William H. Chambers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William H. Chambers United States	27	1.7k	853	622	361	235	88	3.3k
Michael R. Ruff United States	30	875 0.5×	1.3k 1.5×	486 0.8×	269 0.7×	167 0.7×	63	3.9k
Reginald M. Gorczynski Canada	38	2.5k 1.4×	760 0.9×	414 0.7×	167 0.5×	362 1.5×	225	4.6k
Milton W. Taylor United States	29	1.2k 0.7×	1.3k 1.5×	479 0.8×	536 1.5×	247 1.1×	94	3.8k
Eda T. Bloom United States	36	2.9k 1.7×	1.1k 1.3×	1.4k 2.3×	377 1.0×	428 1.8×	95	5.2k
Yacob Weinstein Israel	29	1.5k 0.9×	1.2k 1.4×	530 0.9×	114 0.3×	313 1.3×	85	3.6k
István Berczi Canada	30	880 0.5×	519 0.6×	322 0.5×	348 1.0×	326 1.4×	126	3.0k
Andrew Bateman Canada	40	1.2k 0.7×	2.3k 2.7×	559 0.9×	308 0.9×	368 1.6×	90	6.3k
Brendan Marshall United States	19	2.3k 1.3×	1.0k 1.2×	484 0.8×	709 2.0×	193 0.8×	58	4.5k
Nan‐ping Weng United States	40	2.7k 1.5×	1.3k 1.6×	610 1.0×	167 0.5×	309 1.3×	79	5.6k
John T. Attwood United States	6	1.8k 1.0×	783 0.9×	421 0.7×	666 1.8×	210 0.9×	7	3.7k

Countries citing papers authored by William H. Chambers

Since Specialization

Citations

This map shows the geographic impact of William H. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Chambers more than expected).

Fields of papers citing papers by William H. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Chambers. The network helps show where William H. Chambers may publish in the future.

Co-authorship network of co-authors of William H. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Chambers. A scholar is included among the top collaborators of William H. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Chambers. William H. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flint, Melanie S., et al.. (2012). Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts. Stress. 16(1). 114–121. 49 indexed citations

Warin, Renaud, William H. Chambers, Douglas M. Potter, & Shivendra V. Singh. (2009). Prevention of Mammary Carcinogenesis in MMTV-neuMice by Cruciferous Vegetable Constituent Benzyl Isothiocyanate. Cancer Research. 69(24). 9473–9480. 61 indexed citations

Griffin, Patricia, et al.. (2009). Magnetic resonance imaging–guided adoptive cellular immunotherapy of central nervous system tumors with a T₁ contrast agent. Magnetic Resonance in Medicine. 62(3). 599–606. 7 indexed citations

Witham, Timothy F., Hideho Okada, Wendy Fellows, et al.. (2005). The Characterization of Tumor Apoptosis after Experimental Radiosurgery. Stereotactic and Functional Neurosurgery. 83(1). 17–24. 26 indexed citations

Witham, Timothy F., et al.. (2003). Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo. Journal of Neuro-Oncology. 64(1-2). 63–69. 23 indexed citations

Okada, Hideho, Jason Attanucci, Katinka M. Giezeman‐Smits, et al.. (2001). Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.. PubMed. 61(6). 2625–31. 31 indexed citations

Okada, Hideho, Jason Attanucci, Hideaki Tahara, et al.. (2000). Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy. Cancer Gene Therapy. 7(3). 486–494. 12 indexed citations

Pollack, Ian F., Hideho Okada, & William H. Chambers. (2000). Exploitation of immune mechanisms in the treatment of central nervous system cancer. Seminars in Pediatric Neurology. 7(2). 131–143. 18 indexed citations

Okada, Hideho, Katinka M. Giezeman‐Smits, Hideaki Tahara, et al.. (1999). Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Gene Therapy. 6(2). 219–226. 81 indexed citations

10.

Rogers, Connie J., Cynthia S Brissette-Storkus, William H. Chambers, & Judy L. Cameron. (1999). Acute stress impairs NK cell adhesion and cytotoxicity through CD2, but not LFA-1. Journal of Neuroimmunology. 99(2). 230–241. 14 indexed citations

11.

Gourlay, William A., William H. Chambers, Anthony P. Monaco, & Takashi Maki. (1998). IMPORTANCE OF NATURAL KILLER CELLS IN THE REJECTION OF HAMSTER SKIN XENOGRAFTS. Transplantation. 65(5). 727–734. 36 indexed citations

12.

Bozik, Michael, et al.. (1996). Treatment of 9L gliosarcoma with IL-4 producing 9L vaccine. The FASEB Journal. 10(6). 3 indexed citations

13.

Giardina, S L, Stephen K. Anderson, Thomas J. Sayers, et al.. (1995). Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.. The Journal of Immunology. 154(1). 80–87. 11 indexed citations

14.

Amoscato, Andrew A., et al.. (1994). Surface aminopeptidase activity of rat natural killer cells I. Biochemical and biological properties. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1221(3). 221–232. 6 indexed citations

15.

Amoscato, Andrew A., et al.. (1993). Degradation of Enkephalins by Rat Lymphocyte and Purified Rat Natural Killer Cell Surface Aminopeptidases. Brain Behavior and Immunity. 7(2). 176–187. 8 indexed citations

16.

Chambers, William H., Thomas V. Adamkiewicz, & Jeffrey P. Houchins. (1993). Type II integral membrane proteins with characteristics of C-type animal lectins expressed by natural killer (NK) cells. Glycobiology. 3(1). 9–14. 22 indexed citations

17.

Kaufman, Christina L., William H. Chambers, & Suzanne T. Ildstad. (1993). Coexpression of NKR-P1 and alpha beta-TCR on lymphoid cells in fully xenogeneic (rat➞ mouse) chimeras and syngeneically reconstituted (A➞ A) rats.. The Journal of Immunology. 151(11). 6002–6011. 4 indexed citations

18.

McCoy, J. Philip & William H. Chambers. (1991). Carbohydrates in the functions of natural killer cells. Glycobiology. 1(4). 321–328. 26 indexed citations

19.

Chambers, William H., et al.. (1985). Isolation of bovine eosinophils by density gradient centrifugation. American Journal of Veterinary Research. 46(1). 154–156. 2 indexed citations

20.

Kunz, W.E., et al.. (1971). Spectral hardening during X-ray bursts.. Bulletin of the American Astronomical Society. 3. 262. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact